ArticleClinical medicine insights. Endocrinology and diabetes2026
Clinical Pattern of Graves' Disease and Management Preferences Among Pediatric Endocrinologists in Saudi Arabia, A Decade of Experience.
Article in Clinical medicine insights. Endocrinology and diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Graves' disease (GD) ranks as a primary cause of hyperthyroidism across all age demographics. The clinical presentation, treatment approaches, and overall therapeutic objectives can differ among various age groups. This study aimed to describe the clinical, laboratory, and radiological features, as well as the outcomes of the management of GD within the Saudi pediatric population. Methods: A cross-sectional, multicenter study across 2 tertiary care centers in Saudi Arabia (2010-2021). Clinical, biochemical, and imaging data were collected for children diagnosed with hyperthyroidism under the age of 18, utilizing an electronic medical records system. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 21. Results: We enrolled 93 patients with hyperthyroidism (Mean age at diagnosis = 11.5 years; females = 68, 73.1%). Notably, 40/93 patients (43%) had a significant family history. The primary etiologies were GD (N = 60, 64.5%) and hashitoxicosis (N = 10, 10.8%). The commonest presentations were goiter (57%) and tachycardia (55%). GD was predominantly associated with exophthalmos, lid lag, sweating, tremors, and weight loss (Odds Ratios = 3.71, 3.8, 2.77, 2.34, and 2.28, respectively). An increase in thyroid radioactive iodine uptake was observed in 29/93 patients (48.3%; Conclusion: In our cohort, GD emerged as a leading cause of hyperthyroidism among children and adolescents. Pediatric endocrinologists in Saudi Arabia tend to underutilize RAI and prefer alternative treatment methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.